A novel epsilon gamma delta beta thalassemia presenting with pregnancy complications and severe neonatal anemia. (7th January 2013)
- Record Type:
- Journal Article
- Title:
- A novel epsilon gamma delta beta thalassemia presenting with pregnancy complications and severe neonatal anemia. (7th January 2013)
- Main Title:
- A novel epsilon gamma delta beta thalassemia presenting with pregnancy complications and severe neonatal anemia
- Authors:
- Shalev, Hanna
Landau, Daniela
Pissard, Serge
Krasnov, Tanya
Kapelushnik, Joseph
Gilad, Oded
Broides, Arnon
Dgany, Orly
Tamary, Hannah - Abstract:
- <abstract abstract-type="main" id="ejh12047-abs-0001"> <title>Abstract</title> <sec id="ejh12047-sec-0001" sec-type="section"> <title>Objective</title> <p>The epsilon gamma delta beta (εγδβ)‐thalassemias are rare sporadic disorders caused by deletion of the β‐globin gene cluster. The main clinical feature is marked prenatal and neonatal anemia that resolves spontaneously within a few months. Reports originating mainly from Europe have so far identified 30 such deletions The aim of the present work was to describe a novel 1.78‐Mb deletion, the longest ever reported, and to detail the clinical features in 12 members of an extended Bedouin family.</p> </sec> <sec id="ejh12047-sec-0002" sec-type="section"> <title>Methods</title> <p>The deletion was identified by globin gene multiplex ligation‐dependent probe amplification (MLPA) of the β‐globin cluster and further characterized by comparative genomic hybridization. Past and present clinical and laboratory data of ten symptomatic and two asymptomatic patients were collected.</p> </sec> <sec id="ejh12047-sec-0003" sec-type="section"> <title>Results</title> <p>A 1.78‐Mb εγδβ‐deletion, the largest ever described, was identified in all patients. Although other genes were included in the deletion, no other symptoms were observed. Of the ten symptomatic fetuses and neonates, three died of the disease. The remainder required packed cell transfusions during the first months of life. Pregnancy complications included intrauterine growth<abstract abstract-type="main" id="ejh12047-abs-0001"> <title>Abstract</title> <sec id="ejh12047-sec-0001" sec-type="section"> <title>Objective</title> <p>The epsilon gamma delta beta (εγδβ)‐thalassemias are rare sporadic disorders caused by deletion of the β‐globin gene cluster. The main clinical feature is marked prenatal and neonatal anemia that resolves spontaneously within a few months. Reports originating mainly from Europe have so far identified 30 such deletions The aim of the present work was to describe a novel 1.78‐Mb deletion, the longest ever reported, and to detail the clinical features in 12 members of an extended Bedouin family.</p> </sec> <sec id="ejh12047-sec-0002" sec-type="section"> <title>Methods</title> <p>The deletion was identified by globin gene multiplex ligation‐dependent probe amplification (MLPA) of the β‐globin cluster and further characterized by comparative genomic hybridization. Past and present clinical and laboratory data of ten symptomatic and two asymptomatic patients were collected.</p> </sec> <sec id="ejh12047-sec-0003" sec-type="section"> <title>Results</title> <p>A 1.78‐Mb εγδβ‐deletion, the largest ever described, was identified in all patients. Although other genes were included in the deletion, no other symptoms were observed. Of the ten symptomatic fetuses and neonates, three died of the disease. The remainder required packed cell transfusions during the first months of life. Pregnancy complications included intrauterine growth restriction and oligohydramnios, as well as additional neonatal complications including prematurity and persistent pulmonary hypertension of the neonate.</p> </sec> <sec id="ejh12047-sec-0004" sec-type="section"> <title>Conclusions</title> <p>We suggest that εγδβ‐thalassemia be added to the list of hemoglobinopathies that can cause neonatal anemia and that MLPA of the β‐globin cluster be used to confirm its diagnosis. Careful surveillance during pregnancy is important to reduce neonatal mortality and morbidity, especially given the dramatic improvement that occurs later.</p> </sec> </abstract> … (more)
- Is Part Of:
- European journal of haematology. Volume 90:Number 2(2013:Feb.)
- Journal:
- European journal of haematology
- Issue:
- Volume 90:Number 2(2013:Feb.)
- Issue Display:
- Volume 90, Issue 2 (2013)
- Year:
- 2013
- Volume:
- 90
- Issue:
- 2
- Issue Sort Value:
- 2013-0090-0002-0000
- Page Start:
- 127
- Page End:
- 133
- Publication Date:
- 2013-01-07
- Subjects:
- Hematology -- Periodicals
Blood -- Diseases -- Periodicals
Blood -- Periodicals
616.15005 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1600-0609 ↗
http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=ejh ↗
http://onlinelibrary.wiley.com/ ↗
http://firstsearch.oclc.org ↗ - DOI:
- 10.1111/ejh.12047 ↗
- Languages:
- English
- ISSNs:
- 0902-4441
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.729700
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3306.xml